Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 3
2004 2
2005 2
2012 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Cellular targets of gefitinib.
Brehmer D, Greff Z, Godl K, Blencke S, Kurtenbach A, Weber M, Müller S, Klebl B, Cotten M, Kéri G, Wissing J, Daub H. Brehmer D, et al. Among authors: blencke s. Cancer Res. 2005 Jan 15;65(2):379-82. Cancer Res. 2005. PMID: 15695376 Free article.
Phosphosignature predicts dasatinib response in non-small cell lung cancer.
Klammer M, Kaminski M, Zedler A, Oppermann F, Blencke S, Marx S, Müller S, Tebbe A, Godl K, Schaab C. Klammer M, et al. Among authors: blencke s. Mol Cell Proteomics. 2012 Sep;11(9):651-68. doi: 10.1074/mcp.M111.016410. Epub 2012 May 21. Mol Cell Proteomics. 2012. PMID: 22617229 Free PMC article.
An efficient proteomics method to identify the cellular targets of protein kinase inhibitors.
Godl K, Wissing J, Kurtenbach A, Habenberger P, Blencke S, Gutbrod H, Salassidis K, Stein-Gerlach M, Missio A, Cotten M, Daub H. Godl K, et al. Among authors: blencke s. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15434-9. doi: 10.1073/pnas.2535024100. Epub 2003 Dec 10. Proc Natl Acad Sci U S A. 2003. PMID: 14668439 Free PMC article.